title: Ultrasonic myocardial texture in hypertensive mild-to-moderate left ventricular hypertrophy: a videodensitometric study.
abstract: Myocardial texture analysis of two-dimensional echocardiographic gray level distribution is abnormal in hypertensive patients with severe increase of left ventricular mass. The aim of this study was to investigate the behavior of this parameter in hypertensive patients with absent-to-moderate left ventricular hypertrophy, more representative of the overall hypertensive population. We compared male essential hypertensive patients, with absent or mild-to-moderate left ventricular hypertrophy, with normotensive sedentary healthy subjects as controls. The groups (n = 18 each) were age- (+/- 2 years) and sex-matched. All subjects performed ambulatory blood pressure measurements for the evaluation of 24 h mean systolic and diastolic blood pressure. Quantitative analysis of echocardiographic digitized imaging was performed through a calibrated 256 gray level digitization system to calculate midseptum and midposterior end-diastolic and end-systolic first and second order textural analysis. In particular were observed the mean gray level cyclic variations to deriving the cyclic variation index (CVI). The hypertensives showed a significantly lower CVI compared with controls both for septum (P < .001) and for posterior wall (P < .0001). No significant relationships were found between CVI and relative diastolic thickness both of septum and posterior wall. Conversely, a significant inverse relationship was found between systolic arterial pressure values and CVI both of septum and posterior wall. Abnormalities of two dimensional echocardiographic gray level distribution are present also in hypertensive patients with absent or with mild-to-moderate levels of left ventricular hypertrophy, but seem unrelated to the degree of echocardiographic hypertrophy as such. Changes in collagen network distribution or microcirculatory alterations, secondary to pressure-volume overload per se or to other complex humoral factors, could explain these abnormalities. Further work is needed to establish the clinical, therapeutic, and prognostic implications of these findings.
authors.affiliation: Istituto di Clinica Medica II, University of Pisa, Italy. dibellov@po.ifc.pi.cnr.it
authors.forename: V
authors.initials: V
authors.lastname: Di Bello
authors.forename: R
authors.initials: R
authors.lastname: Pedrinelli
authors.forename: M
authors.initials: M
authors.lastname: Bianchi
authors.forename: D
authors.initials: D
authors.lastname: Giorgi
authors.forename: A
authors.initials: A
authors.lastname: Bertini
authors.forename: G
authors.initials: G
authors.lastname: Valenti
authors.forename: S
authors.initials: S
authors.lastname: Ghione
authors.forename: A
authors.initials: A
authors.lastname: Corchia
authors.forename: G
authors.initials: G
authors.lastname: Dell'Omo
authors.forename: M
authors.initials: M
authors.lastname: Paterni
authors.forename: C
authors.initials: C
authors.lastname: Giusti
mesh_terms: D000328:Adult; D000368:Aged; D003720:Densitometry; D004452:Echocardiography; D006801:Humans; D006973:Hypertension / Q000000981:diagnostic imaging* / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000000981:diagnostic imaging*; D008297:Male; D008875:Middle Aged